Pfizer has announced a revised profit estimate for 2025, underpinned by a cost-cutting program, amid falling COVID product revenues and patent expirations. Shares rose 3.7% after the company reported a better-than-expected quarterly profit. However, Pfizer remains cautious, maintaining annual sales forecasts of between $61 billion and $64 billion, due to pandemic uncertainties and political pressure to cut drug prices.
Sources
Pfizer își majorează estimarea de profit pentru 2025, pe fondul reducerilor masive de costuri și al presiunilor politice din partea lui Trump
Pfizer își ridică prognoza de profit pentru 2025, mizând pe reduceri agresive de costuri și negocieri
Pfizer îşi majorează estimarea de profit pentru 2025, pe fondul reducerilor masive de costuri şi al presiunilor politice din partea lui Trump
Pfizer îşi majorează estimarea de profit pentru 2025, pe fondul reducerilor masive de costuri şi al presiunilor politice din partea lui Trump
Latest News
17:02
Interim Prime Minister Ilie Bolojan announced the launch of the program 'Diaspora Invests at Home', aimed at Romanians in the diaspora who wish to establish businesses in Romania, with a budget of 100 million euros.
16:50
People who ride electric scooters or motorized vehicles in parks and public gardens in Sector 1 risk fines of up to 5,000 lei
16:38
Three Chinese citizens were stopped at the western border of Romania with counterfeit visas, apparently issued by Poland.
16:30
Three people were taken to the hospital after a gas leak in Bragadiru. Two individuals are unconscious.
16:21
Vasile Tofan, the Prime Minister of the Republic of Moldova, acknowledged the difficulties in the energy system and the risk of not being able to procure the necessary energy.
See more news